Clinical Trials List
2014-03-01 - 2019-08-26
Phase II
Terminated3
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/19
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林孟志 Division of Thoracic Medicine
- 賴建豪 Division of Thoracic Medicine
- 李易濰 Division of Radiology
- Shau-Hsuan Li Division of Hematology & Oncology
- 王逸熙 Division of Thoracic Medicine
- 鍾聿修 Division of Thoracic Medicine
- 林理涵 Division of Radiology
- 張晃智 Division of Thoracic Medicine
- 趙東瀛 Division of Thoracic Medicine
- 饒坤銘 Division of Hematology & Oncology
- Chia-Cheng Tseng Division of Thoracic Medicine
- 黃國棟 Division of Thoracic Medicine
- 陳彥豪 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yu-Min Yeh Division of General Internal Medicine
- Jui-Hung Tsai Division of General Internal Medicine
- Wei-Pang Chung Division of General Internal Medicine
- Wu-Chou Su Division of General Internal Medicine
- Chien-Chung Lin Division of General Internal Medicine
- Wen-Pin Su Division of General Internal Medicine
- Seu-Chun Yang Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
60 participants
